Mylan asks US court to clear Wegovy generic from Novo patent claims ↧ ↧ Mylan asks US court to clear Wegovy generic from Novo patent claims Generic drugmaker Viatris has sued Danish pharmaceutical giant Novo Nordisk in Delaware federal court, seeking a ruling that its proposed generic of Novo's blockbuster GLP-1 drug Wegovy would not violate Novo's patent rights.
published
Mylan asks US court to clear Wegovy generic from Novo patent claims ↧
Open the original public source →
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.